Sphere Fluidics
Booth Number 518, Poster Number 83
December 15-18, 2024
Marriott Marquis San Diego
San Diego, CA, USA
Join us at the Antibody Engineering & Therapeutics conference, where the latest breakthroughs in antibody research are unveiled. This event will cover crucial topics such as Neurodegenerative Diseases, Tumor Microenvironment in Antibody Therapy, Bi-Specifics, ADCs, and more. Network with global experts and stay ahead in antibody-related research and development.
Insights and Innovations
Join Sphere Fluidics for a Poster Showcase
Picodroplets for Biologics Discovery and Cell Line Development: Accelerating the Discovery and Development Process
John Lesnick
Designated Odd Number Poster Presentation Time: Dec 17, 6:15pm-7:15pm
The poster will be available to view openly anytime following 4:00pm on Monday, December 16th until breakdown time on Wednesday, December 18th
POSTER DETAILS
Picodroplets for Biologics Discovery and Cell Line Development: Accelerating the Discovery and Development Process
Although antibody therapeutics dominate drug development, prolonged workflows and increasing costs during their discovery and development hinder their success. Cyto-Mine® offers significant advantages in the number of cells that can be processed, cost per run, and the speed with which projects can be completed. Sphere Fluidics has developed Cyto-Mine® Chroma – a new instrument – that enables the use of more fluors, multiplexed assays, and a broader range of applications. Early applications of the Cyto-Mine® Chroma platform will enable cell isolation based on cell surface markers, viability, and titer of secreted proteins. Moreover, in combination with re-injection-based workflows, it will facilitate complex assays like combining more than one cell type in a single droplet (crucial for binding assessment, cytotoxic assays, and advancing antibody development).
View our latest poster presentation featuring Cyto-Mine®Chroma
Highlights Include:
Faster project completion
Multiplexing capabilities
Rapid identification and isolation of rare cells
Assurance of monoclonality in selected cells
